OSTIA
LIVE

Serial Number

99421937

Owner

Ostia Sciences Inc.

Attorney

Maria A. Scungio

Filing Date

Sep 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OSTIA Trademark

Serial Number: 99421937

OSTIA is a trademark filed by Ostia Sciences Inc. on September 30, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ostia Sciences Inc. (2 trademarks)

124 Edward St.
Toronto, ON M5G 1G6

Entity Type: 11

Trademark Details

Filing Date

September 30, 2025

Registration Date

Not Registered

Goods & Services

Probiotic bacteria for use in the manufacture of biochemicals; Probiotic bacteria for use in the manufacture of food and beverages; Bacterial cultures for addition to food products; Cultures of microorganisms other than for medical or veterinary use; Bacterial preparations, other than for medical and veterinary use; Bacterial preparations for the food industry; Biological preparation for use in cell cultures other than for medical or veterinary use; Microbes for use in the manufacture of probiotic supplements; Viruses for research use; Biological preparations for use in industry and science

Probiotic supplements; Nutritional supplements, namely, probiotic compositions; Probiotic preparations for medical use; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical preparations for treating halitosis; Dietetic preparations adapted for medical purposes; Medicinal preparations for the mouth and as sprays; Medicated throat sprays; Medicated mouthwash; Medicated dental rinses; Oral analgesics; Medicated lozenges; Cough drops; Medicated chewing gum; Beverages containing probiotics for use as a nutritional supplement

Pharmaceutical product evaluation; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research; Research and development of new products in the field of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of vaccines and medicines; Technical consulting in the field of pharmaceutical studies; Development of computer platforms; Scientific research in the nature of conducting clinical trials for others; Product development for others; Research and development services in the field of biotechnology; Consulting services for others in the field of design, planning, and implementation project management of clinical trials

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 30, 2025 MAFR
NEW APPLICATION ENTERED
Sep 30, 2025 NWAP